A9T-2101

N/A

Report date: 2024/01/12 11:14:46

Base Information

Drug NameA9T-2101
Drug Alias NameA9T-2101
ClassificationDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Radioactive diagnostic agent
Mechanisms of ActionRadionuclide imaging enhancers
TargetsUpdating
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlpha-9 Oncology Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlpha-9 Oncology Inc
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A